In this webinar, we provide an overview of intranasal vaccine formulations for liquid and powder administration. We then discuss the pros and cons of nasal vaccines, assess intranasal device platforms, logistical considerations that need to be taken into account, as well as present our thoughts on the opportunities that intranasal vaccination can offer.
Intranasal Immunization: Promises and Challenges
Today, there are three marketed nasal vaccines available for human use but many more are in development for both human and veterinary use.
Nasal vaccination provides an alternative to the more conventional Injectable drug delivery system. Mucosal immunity can develop via interaction with immune modulators present in the nasal cavity, where the nasal associated lymphoid tissue (NALT) region plays a dominant role.
Subscribe to Email Updates
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.
Requesting access to Intranasal Immunization: Promises and Challenges.